Back to top
Asunra 400 mg Tablet
Asunra 400 mg Tablet

Asunra 400 mg Tablet

Asunra 400 mg Tablet Specification

  • Origin of Medicine
  • Allopathic
  • Pacakaging (Quantity Per Box)
  • 10 tablets per strip 1 strip per box
  • Salt Composition
  • Deferasirox
  • Drug Type
  • Tablet
  • Ingredients
  • Deferasirox
  • Physical Form
  • Tablet
  • Function
  • Iron Chelating Agent
  • Recommended For
  • Treatment of chronic iron overload due to frequent blood transfusions
  • Dosage
  • 400 mg
  • Dosage Guidelines
  • Once daily as prescribed by a healthcare professional
  • Suitable For
  • Adults and children above 2 years
  • Quantity
  • 1 strip of 10 tablets
  • Storage Instructions
  • Store in a cool dry place below 30°C away from direct sunlight
 
 

About Asunra 400 mg Tablet



Asunra 400 mg Tablet is a potent iron chelating agent containing Deferasirox as the active ingredient. It is designed for the treatment of chronic iron overload resulting from frequent blood transfusions. Each tablet, with a dosage of 400 mg, is suitable for adults and children above 2 years of age. The recommended dosage is once daily as prescribed by a healthcare professional. This Allopathic medication is presented in a strip containing 10 tablets and is to be stored in a cool, dry place below 30C away from direct sunlight.

FAQs of Asunra 400 mg Tablet:


Q: What is Asunra 400 mg Tablet used for?

A: Asunra 400 mg Tablet is used as an iron chelating agent for treating chronic iron overload caused by frequent blood transfusions.

Q: What is the dosage of Asunra 400 mg Tablet?

A: The dosage of Asunra 400 mg Tablet is 400 mg to be taken once daily as recommended by a healthcare professional.

Q: Is Asunra 400 mg Tablet suitable for children?

A: Yes, Asunra 400 mg Tablet is suitable for children above 2 years of age in addition to adults.

Q: How should Asunra 400 mg Tablet be stored?

A: Asunra 400 mg Tablet should be stored in a cool, dry place below 30C away from direct sunlight.

Q: What is the composition of Asunra 400 mg Tablet?

A: Asunra 400 mg Tablet contains Deferasirox as its salt composition and active ingredient.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Critical Care Category

Bharglob 16.5% Injection

Bharglob 16.5% Injection

Salt Composition : Human Immunoglobulin G (IgG) 16.5%

Recommended For : Immunodeficiency disorders specific infections and autoimmune conditions

Dosage Guidelines : Administered under strict medical supervision

Quantity : 100 ml

Pacakaging (Quantity Per Box) : 1 vial per box

Function : Other, Provides passive immunity against infections by boosting immunity

Fragmin 2500 IU Injection

Fragmin 2500 IU Injection

Salt Composition : Dalteparin Sodium (2500 IU)

Recommended For : Patients at risk of thrombosis or undergoing surgery

Dosage Guidelines : As prescribed by the physician; typically administered subcutaneously.

Quantity : 1 vial

Pacakaging (Quantity Per Box) : 1 injection per box

Function : Other, Prevention of blood clots

Rasby 1.5 mg Injection

Rasby 1.5 mg Injection

Salt Composition : Rasburicase (1.5 mg)

Recommended For : Patients undergoing cancer treatment with a risk of tumor lysis syndrome

Dosage Guidelines : To be administered intravenously under medical supervision

Quantity : 1 vial

Pacakaging (Quantity Per Box) : 1 vial per box

Function : Other, Prevents high uric acid levels during chemotherapy

Xarelto 20 mg Tablet

Xarelto 20 mg Tablet

Salt Composition : Rivaroxaban

Recommended For : Adults with clotting disorders such as DVT and PE and those at risk of stroke due to atrial fibrillation

Dosage Guidelines : As prescribed by a healthcare professional usually taken once daily with food

Quantity : Packaging typically contains 10 or 30 tablets per blister pack

Pacakaging (Quantity Per Box) : 10 or 30 tablets per box

Function : Other, Prevention of blood clots in conditions like deep vein thrombosis (DVT) pulmonary embolism (PE) and other clotting disorders